Syngene International's Stock Sees -3.36% Decline, Remains Strong in Pharma Industry

Syngene International, a leading pharma company in the largecap industry, has seen a decline of -3.36% in its stock price on February 28, 2024. According to MarketsMOJO, the stock has been given a 'Hold' call.

The stock's performance today has underperformed the sector by -2.16%. It has also been on a consecutive fall for the last 4 days, with a total decline of -5.68% during this period. The stock touched an intraday low of Rs 705.55 (-2.95%).

Syngene International is currently trading below its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages, indicating a downward trend in its stock price.

In comparison to the Sensex, Syngene International's 1 day performance is -3.29%, while the Sensex's performance is -1.08%. Over the past month, Syngene International has seen a 2.48% increase in its stock price, slightly outperforming the Sensex's 2.27% increase.

Despite the recent decline in its stock price, Syngene International remains a strong player in the pharma industry. Investors are advised to hold onto their stocks and monitor the company's performance in the coming days. This is not a recommendation, but rather a fact-based analysis of the company's current stock performance.